AMBioVessel – 3D-printed, tailor-made bioreactors for pharma and medicine
The consortium will develop within the framework of a Eurostars collaboration project the AMBioVessel system, the first application driven designed bioreactor produced by additive manufacturing.
Description
The consortium will develop within the framework of a Eurostars collaboration project the AMBioVessel system, the first application driven designed bioreactor produced by additive manufacturing. It will introduce a paradigm shift from tuning environmental parameters to modifying the spatial environment of the culture. The AMBioVessel offers perfect cultivation environments to achieve product yields beyond the current bioreactor geometry limitations that allow faster time-to-market and cost reduction for bio-manufacturing and cell therapy, our main target markets.
Key data
Projectlead
Prof. Dr. Dieter Eibl
Deputy Projectlead
Project team
Sandra Steiner, Dr. Jan Ott, Valentin Jossen, Dr. Stefan Seidel, Samuel Schneider
Project partners
Levitronix GmbH; PreSens Precision Sensing GmbH; Applikon Biotechnology B.V.; Neue Materialien Bayreuth GmbH
Project status
completed, 05/2020 - 12/2023
Institute/Centre
Institute of Chemistry and Biotechnology (ICBT)
Funding partner
Eurostars / Projekt Nr. 113750
Prof. Dr. Ing. Regine Eibl-Schindler
School of Life Sciences and Facility Management
Einsiedlerstrasse 34
8820 Wädenswil